Muscarinic receptors: new potential for treating chronic pain.
A new approach using small molecules that selectively activate a specific subtype of the muscarinic receptor is showing considerable promise at ACADIA Pharmaceuticals (San Diego, CA, USA) for the treatment of chronic pain.